**About the Special Issue Editors**

**Sabzali Javadov** M.D., Ph.D. completed his MD at the Russian Medical University, Moscow, in 1983, his PhD at the Russian Cardiology Center, Moscow, in 1986, and his DSc at the Moscow University, in 1992. He worked as a postdoctoral researcher and a visiting scientist at Magdeburg Medical University, Germany (1987), National Institute of Cardiology, Hungary (1991), University of Bristol, England (1997–2001), and Western University, Canada (2003–2008). Since 2009, he has been a professor at the Department of Physiology at the University of Puerto Rico School of Medicine, USA. Dr. Javadov has specific training and expertise in cardiac biochemistry and physiology, with a focus on the role of mitochondria in cardiac dysfunction induced by ischemia-reperfusion and heart failure. Currently, his laboratory elucidates the relationship between mitochondrial reactive oxygen species, permeability transition, and electron transport chain supercomplexes in myocardial infarction. Dr. Javadov has published over 100 papers in reputed journals and books and has served as an editorial board member for numerous biomedical journals. He has served as a review committee member for research foundations in the USA and Europe.

**Andrey V. Kozlov** M.D., Ph.D. completed his MD in 1980 and his PhD in 1986 for studies in medical biophysics from the Russian State Medical University (Moscow, Russia). In 2003, he received his habilitation (post-doctoral lecturing qualification) in pharmacology and toxicology at the University of Veterinary Medicine (Vienna, Austria). He worked as a postdoctoral researcher at the Institute of General Pathology, University of Modena (1993–1994, Modena, Italy), at the Department of Occupational and Environmental Health and Toxicology, University of Pittsburgh (1995, Pittsburgh, USA), and at the University of Veterinary Medicine (1996–2003, Vienna, Austria). Currently, he is the deputy director of, and principle investigator at, the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology (Vienna, Austria). Dr. Kozlov's research has focused on metabolic disorders induced by hypoxia and inflammation occurring in shock, sepsis, ischemia-reperfusion, and more recently in neurotrauma. Particular attention is given to the function/dysfunction of subcellular organelles, mitochondria and endoplasmic reticulum, reactive oxygen and nitrogen species, free iron metabolism, oxidative stress reactions, and the pharmacology and toxicology of nitric oxide. He has published over 100 articles (original and review articles and book chapters), and serves on the editorial boards of several journals related to his research area.

**Amadou K.S. Camara** Ph.D. completed his PhD in renal and cardiovascular physiology at the Department of Physiology, Medical College of Wisconsin (MCW), in 1995. His dissertation focused on the brain renin angiotensin-aldosterone system, seeking to understand the mechanisms of renal neurogenic hypertension following a chronic NaCl diet in rats. From 1995–1999, he completed his postdoctoral training in cardiac electrophysiology at the Department of Anesthesiology, MCW. In 2000, he was elevated to the position of assistant professor in the department. In 2013, he was promoted to professor and was awarded a tenure in 2018. Dr. Camara's research has focused on cardiac physiology/pathophysiology, with an emphasis on ischemia reperfusion injury and cardioprotective strategies targeted to mitochondria. In particular, he studies mitochondrial Ca2+ regulation, with an emphasis on the molecular components responsible for Ca2+ efflux/influx (mitochondrial Ca2+ uniporter, Na+/Ca2+ exchanger, voltage-dependent anion channel), mitochondrial buffering capacity and the role of reactive oxygen species under normal

and IR injury conditions. With his background in neuroscience, he has recently embarked on an investigation of the role of mitochondria in mild traumatic brain injury. He has published over 100 articles (original and review articles and book chapters) on IR and mitochondria-related studies. He has recently co-sponsored four Special Issues on mitochondria, served on numerous editorial boards, and been an ad hoc reviewer for more than two dozen journals. Dr. Camara has served on NIH study sections and has reviewed for numerous international gran<sup>t</sup> organizations, including the Medical Research Council, England.
